› $150,000,000 verdict in personal injury case
A group of parents have filed a lawsuit against the makers of Zoloft alleging the antidepressant caused their children severe birth defects. The lawsuit was filed in St. Clair County Circuit Court against Pfizer Inc.
Using antidepressant known as selective serotonin reuptake inhibitors, or SSRIs, during pregnancy can increase the risk of various birth defects, whether the drugs are used early or late in pregnancy, according to two studies published in the past six months.
One in five adults in the United States suffered from mental illness last year, and women were far more likely than men to have been diagnosed with mental, behavioral or emotional disorders, according to a newly released government study.
The Food and Drug Administration (FDA) is giving health care professionals the green light to continue prescribing a class of antidepressants to pregnant women despite a 2006 warning that the drugs may cause newborns to be born with persistent pulmonary hypertension (PPHN). The agency’s earlier warning was based on a study that showed an increased risk for fetuses to develop the condition if they were exposed to selective serotonin reuptake inhibitors (SSRIs) after 20 weeks gestation. Since then, the agency says there have been conflicting studies evaluating this risk, making it unclear just how dangerous SSRIs are to developing fetuses.
Clinical trials testing experimental and currently marketed pharmaceutical drugs help determine the medication’s safety and efficacy. This information is vital to policy makers and doctors, who generally read about these studies in peer-reviewed medical journals. But only a fraction of data from these clinical trails is ever published, a travesty that both “distorts scientific record” and puts patients lives at risk, the British Medical Journal warns.
More babies are born with birth defects in England and Wales than previously thought, according to a recent study from Queen Mary, University of London. At least 14,500 babies were born in 2009 with defects such as congenital heart disease, spina bifida and gastroschisis. That represents more than 2 percent of births, up from previous estimates of 1.3 percent. The data comes from five regional birth defect registries as well as two additional registries specific to particular conditions.
New studies suggest use of antidepressants during pregnancy may contribute to an increased risk of heart defects in newborns, but the Food and Drug Administration (FDA) says it is too soon to issue any specific warnings about that risk.
Parents of children with birth defects who were exposed to the antidepressant Zoloft during gestation are suing the drug maker claiming the mothers took the antidepressant only because they believed it to be a safe medication to take during pregnancy.
The number of children in the United States enrolled in special education programs for autism spectrum disorders has increased from 22,664 in 2004 to 193,637 in 2005. Coincidentally, between 1996 and 2005, the number of Americans taking antidepressants nearly doubled to about 10 percent of the population. This relationship alone had some researchers wondering if there might be a link between the two different statistics. Now, a new study supports that assumption.
Pregnant women carry a huge responsibility. Everything thing they do or ingest could potentially affect their unborn child. But when the mother is experiencing health problems that can be treated by medication, she has only to go by the advice of her doctor and the information provided by the drug company that makes the medication.
